You are here

Conference on Nausea and Vomiting: management of nausea and vomiting – the European vision

by Fausto Roila, recorded at TAO (Transatlantic Oncology meeting), Nov 20-21, 2014, Paris

18- Fausto Roila ANG

The emetic risk of chemotherapy regimens can be classified as minimal, low, moderate or high. Fausto Roila reviews the study results of various antiemetics, including dosing, adverse events and cost-effectiveness. He discusses the beneficial effects of adding NK1 receptor antagonists.

Fausto Roila, Ospedale S. Maria di Terni, Italy

Search this site

Featured videos

Free access to ebooks on cachexia and CINV


Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

Cancer cachexia: mechanisms and progress in treatment


Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo